ArticleNature chemistry2026
Construction of synthetic protein-binding non-genetic DNA systems in living cells.
Article in Nature chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Life's development and adaption to fluctuating environments are underpinned by DNA-protein interactions, which have also spurred the development of artificial systems ranging from genetic circuits to nanoarchitectures. Nonetheless, in cellulo there remains an untapped design space for DNA-protein systems that are incompatible with the role of DNA as genetic material. Here we engineer retrons to intracellularly express non-genetic small DNAs embedding specific protein-binding sequences. These DNA species are products of genes and therefore their quantitative, spatial and functional control is decoupled from genetic stability, enabling alternative architectures of DNA-protein systems with unique functions. Using synthetic networks of proteins and the engineered retron-DNA, we demonstrated precise, multiplexed gene regulation and construction of feedback circuits for dynamic responses. Further, we developed DNA-based molecular scaffolds and bridges that enable modular, post-translational and spatial control of multiple proteins within cells. Finally, we transformed an allosteric transcription factor into inducible post-translational switches. Our work suggests that the non-genetic DNA-protein systems represent a promising control layer for creating synthetic cellular behaviours.
Indexed as
Identifiers
41545691What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.